Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader. Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.12 | 7.36196319018 | 1.63 | 1.9 | 1.53 | 100861 | 1.70816344 | CS |
4 | -0.11 | -5.91397849462 | 1.86 | 1.94 | 1.43 | 73390 | 1.66745156 | CS |
12 | -0.7 | -28.5714285714 | 2.45 | 7.2 | 1.35 | 2626725 | 2.74181601 | CS |
26 | -3.5268 | -66.8359611886 | 5.2768 | 7.2 | 1.35 | 1263439 | 2.80580231 | CS |
52 | -4.7404 | -73.0371009491 | 6.4904 | 7.6 | 1.35 | 657942 | 2.88798993 | CS |
156 | -208.25 | -99.1666666667 | 210 | 240 | 1.35 | 483143 | 39.77952998 | CS |
260 | -1162.25 | -99.8496563574 | 1164 | 1350 | 1.35 | 665815 | 184.06934461 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.